Skip navigation

Overcome Patient Affordability Barriers in an Evolving Managed Care Landscape

April 21-23, 2020
  • San Francisco, CA

Facilitating patient affordability and access to medication is one of the greatest ongoing areas of concern for pharma/biotech companies. While this is difficult in and of itself, companies must also navigate increased efforts from health plans to limit reimbursement of high cost therapeutics. Challenges continue to arise for manufacturers including accumulator programs, state-level copay legislation, formulary exclusions, high deductible plans, changes in benefit design, NDC blocks and step therapy programs.

CBI’s Formulary, CoPay and Access Summit provides a forum for industry to convene, benchmark and gain strategies to navigate new and impending access challenges within the value-based landscape while providing valuable patient services and support including coupons, co-pays and bridge programs.

Featured Content Includes:

  • Explore perspectives on accumulator adjustment programs and identify trends for the future
  • Demystify state-level copay card legislation and assess implications of future state-level regulations
  • Overcome challenges of high-deductible plans, copay caps and the evolving healthcare landscape
  • Gain insight on strategies for fast tracking prior authorization and copay assistance for specialty prescriptions
  • Gain insight on key stakeholder challenges to discover new methods for manufacturers to collaborate with payers, pharmacists and physicians to improve patient outcomes
  • Determine the impact of the growing biosimilars market on formulary placement across various care models including hospital, IDN and retail pharmacies
  • Field multiple offers at the same time including PNMT offers, Dollars off, Vouchers and PAP programs
  • Develop best practices to communicate with field reps when
    there are issues with co-pay cards

The conference provided the knowledge I was anticipating and looking for. I appreciated the level of different topics that provided solutions to the issues and challenges faced today by manufacturers utilizing co-pay off-set strategies

Vice President, Industry Relations and Managed Markets, City Drugs Specialty Pharmacy

Excellent appraisal of approaches and philosophies
in market access and engagement.

Sr. Director, Quality Strategic Consumer Group,  J&J Health Care Systems

A cost-effective way to learn from thought leaders, peers and vendors in a topic area of interest. Especially useful at the beginning of the year to set performance goals and think of new approaches to explore during the year.

Assistant Director, Payer Marketing, Acorda Therapeutics

The conference helped me understand the barriers and challenges on the manufacturer and the pharmacy sides

Supervisor Patient Engagement and Customer, Vanderbilt Specialty Pharmacy Service

If you want to know the details about what is going on in the U.S. health marketplace, you can’t go wrong with this conference. The high level of detail is not covered by anyone else. The buzz at this event was that every attendee learned something new

Advocacy Director, Little Hercules Foundations

6th Annual Formulary, Copay and Access

Overcome Patient Affordability Barriers in an Evolving Managed Care Landscape

Facilitating patient affordability and access to medication is one of the greatest ongoing areas of concern for pharma/biotech companies. While this is difficult in and of itself, companies must also navigate increased efforts from health plans to limit reimbursement of high cost therapeutics. Challenges continue to arise for manufacturers including accumulator programs, state-level copay legislation, formulary exclusions, high deductible plans, changes in benefit design, NDC blocks and step therapy programs.

CBI’s Formulary, CoPay and Access Summit provides a forum for industry to convene, benchmark and gain strategies to navigate new and impending access challenges within the value-based landscape while providing valuable patient services and support including coupons, co-pays and bridge programs.

Featured Content Includes:

  • Explore perspectives on accumulator adjustment programs and identify trends for the future
  • Demystify state-level copay card legislation and assess implications of future state-level regulations
  • Overcome challenges of high-deductible plans, copay caps and the evolving healthcare landscape
  • Gain insight on strategies for fast tracking prior authorization and copay assistance for specialty prescriptions
  • Gain insight on key stakeholder challenges to discover new methods for manufacturers to collaborate with payers, pharmacists and physicians to improve patient outcomes
  • Determine the impact of the growing biosimilars market on formulary placement across various care models including hospital, IDN and retail pharmacies
  • Field multiple offers at the same time including PNMT offers, Dollars off, Vouchers and PAP programs
  • Develop best practices to communicate with field reps when
    there are issues with co-pay cards

The conference provided the knowledge I was anticipating and looking for. I appreciated the level of different topics that provided solutions to the issues and challenges faced today by manufacturers utilizing co-pay off-set strategies

Vice President, Industry Relations and Managed Markets, City Drugs Specialty Pharmacy

Excellent appraisal of approaches and philosophies
in market access and engagement.

Sr. Director, Quality Strategic Consumer Group,  J&J Health Care Systems

A cost-effective way to learn from thought leaders, peers and vendors in a topic area of interest. Especially useful at the beginning of the year to set performance goals and think of new approaches to explore during the year.

Assistant Director, Payer Marketing, Acorda Therapeutics

The conference helped me understand the barriers and challenges on the manufacturer and the pharmacy sides

Supervisor Patient Engagement and Customer, Vanderbilt Specialty Pharmacy Service

If you want to know the details about what is going on in the U.S. health marketplace, you can’t go wrong with this conference. The high level of detail is not covered by anyone else. The buzz at this event was that every attendee learned something new

Advocacy Director, Little Hercules Foundations